↓ Skip to main content

Integrating anoikis and ErbB signaling insights with machine learning and single-cell analysis for predicting prognosis and immune-targeted therapy outcomes in hepatocellular carcinoma

Overview of attention for article published in Frontiers in immunology, October 2024
Altmetric Badge

Mentioned by

twitter
1 X user